Conference
Secukinumab provides greater cumulative 52-week skin clearance and quality of life benefit in patients with moderate-to-severe plaque psoriasis than ustekinumab: An area under the curve analysis
Authors
Vender R; Leonardi C; Puig L; Ziv M; Zhao Y; Gilloteau I; McLeod L; Nyirady J; Guana A
Volume
76
Pagination
pp. AB231-AB231
Publisher
MOSBY-ELSEVIER
Publication Date
June 1, 2017
Name of conference
Annual Meeting of the American-Academy-of-Dermatology
Conference place
Orlando, FL
Conference start date
March 3, 2017
Conference end date
March 7, 2017
Conference proceedings
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Issue
6
ISSN
0190-9622